Status:
UNKNOWN
Evaluation of Therapeutic Efficacy in Use of Chamomilla Gel, Chamomilla Infuse and Urea in Radiodermatitis
Lead Sponsor:
University of Brasilia
Collaborating Sponsors:
University of Washington
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Conditions:
Radiodermatitis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study aims to evaluate therapeutics interventions in radiodermatitis in patients with breast or head and neck cancer. The data collect is going to begin after determining the better dose in a dos...
Detailed Description
Hypothesis: Chamomila gel is more effective than urea (usual care); Chamomila infuse is more effective than urea (usual care); Chamomila gel is more effective than chamomila infuse; Chamomila infuse ...
Eligibility Criteria
Inclusion
- Being an adult, over the age of 18 years old; Owning diagnosis of breast or head and neck cancer; Being first referred to the radiotherapy protocol; Presenting radiodermatitis grades 1 or 2, second RTOG score, in the place where is receiving radiation therapy; No history of previous hypersensitivity reaction to chamomile or any plant of the Asteraceae or Compositae family or Urea; Demonstrate understanding to continue the intervention in their home environment when necessary.
Exclusion
- Medical prescription, during the process of data collection, some kind of intervention to prevent radiodermatitis
Key Trial Info
Start Date :
August 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02251392
Start Date
August 1 2015
End Date
December 1 2016
Last Update
December 2 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.